News and Events

CDR recommendation is now available for Repatha

February 25, 2016

Files Submission Status Report Recommendation and Reasons Evolocumab Published on: June 4, 2015 Result type: Reports Project Number: SR0441-000 Product Line: Common Drug Review Project Status: Active Generic Name: Evolocumab.

JUXTAPID™ (lomitapide) Capsules Available on the Régie de l’Assurance Maladie du Québec (RAMQ) for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)

January 5, 2016

TORONTO, Nov. 20, 2015 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients.

FH Patient and Healthcare Professional Resources

December 4, 2015

Patient Resources: FH Patient Leaflet (English) FH Patient Leaflet (French) A Guide to Fh patients (English) A Guide to FH for Patients (French) Healthcare Professional.

NEW LOCATION: The FH Canada Patient Network invites you to a “first-ever” Canadian public meeting: October 24, 2015

October 15, 2015

The FH Canada Patient Network invites you to a “first-ever” Canadian public meeting … all about LDL cholesterol. How does LDL-C effect people? How big.

CDR recommendation is now available for Repatha

JUXTAPID™ (lomitapide) Capsules Available on the Régie de l’Assurance Maladie du Québec (RAMQ) for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)

FH Patient and Healthcare Professional Resources

NEW LOCATION: The FH Canada Patient Network invites you to a “first-ever” Canadian public meeting: October 24, 2015

ASCVD (coronary artery disease) Questionnaire

Request for Personal Feedback

Patient Feedback on NEW treatment for High Cholesterol